Hesperos is a global contract research organization (CRO) specializing in preclinical drug development services through its Human-on-a-Chip® platform. By replicating key aspects of human biology (and thus avoiding expensive, time-consuming and often less informative animal testing), Human-on-a-Chip® platform models provide product development teams with more meaningful insights that can accurately predict an agent’s therapeutic profile while lowering costs and accelerating development timelines.